학술논문
Mesothelin-targeted bispecific antibodies drive synthetic agonistic receptor – Transduced T cells to mediate specific and conditional therapy of human pancreatic cancer models
Document Type
Abstract
Author
Source
In European Journal of Cancer March 2018 92 Supplement 1:S20-S20
Subject
Language
ISSN
0959-8049